Growing evidence suggests that there is still hope that HSP inhibition can be used in MPN, especially seeing that other members of the HSP family, such as HSP27, have recently emerged as proteins of interest in MF. This evidence concerns the gene HSP90B2P and myeloproliferative disorder.